bioRxiv · 10.1101/677443
Rare protein-altering variants in ANGPTL7 lower intraocular pressure and protect against glaucoma
Abstract
Protein-altering variants that are protective against human disease provide in vivo validation of therapeutic targets. Here we use genotyping data in UK Biobank and FinnGen to conduct a search for protein-altering variants conferring lower intraocular pressure (IOP) and protection against glaucoma. Through protein-altering variant association analysis we find a missense variant in UK Biobank (rs28991009 (MAF=0.8%) genotyped in 81,527 individuals with measured IOP and an independent set of 4,269 glaucoma patients and 251,355 controls) that significantly lowers IOP ({beta} = -0.73 mmHg for heterozygotes, -2.96 mmHg for homozygotes, P = 1 x 10-13) and is associated with 34% reduced risk of glaucoma (P = 0.005). In FinnGen, we identify an ANGPTL7 missense variant at a greater than 50-fold increased frequency in Finland compared with other populations (rs147660927, p.Arg220Cys, MAF Finland = 4.1%), which was genotyped in 5,177 glaucoma patients and 130,461 controls and is associated with 30% lower glaucoma risk (P = 1 x 10-9). We further find three rarer variants in UK Biobank, including a protein-truncating variant, which confer a strong composite lowering of IOP (P = 0.002), suggesting the protective mechanism likely resides in the loss of an interaction or function. Our results support inhibition or down-regulation of ANGPTL7 as a therapeutic strategy for glaucoma
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Tanigawa, Y., Wainberg, M., Karjalainen, J., Kiiskinen, T., Lemmelä, S., Turunen, J. A., Palotie, A., FinnGen,, Daly, M., Rivas, M. A.. 2019-06-26. Rare protein-altering variants in ANGPTL7 lower intraocular pressure and protect against glaucoma. https://doi.org/10.1101/677443
Cite the original work for its findings. Save a collection to share your selection of sources.